{"pageContent": "Purpose: Many patients who undergo surgery or radiation therapy to treat localized prostate cancer experience an increase in serum prostate specific antigen (PSA) after treatment. This study documents patterns of PSA recurrence after surgery or radiation to treat localized prostate cancer and quantifies the extent to which an increasing PSA predicts death from prostate cancer.", "metaData": {"source": "Prostate cancer: where we have been, where we are, and where we are going\nhttps://pubmed.ncbi.nlm.nih.gov/23763880/"}}